TECTONIC THERAPEUTIC INC. - COMMON STOCK

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

11 نوفمبر 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

07 نوفمبر 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

22 أكتوبر 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

19 سبتمبر 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic to Participate in September Investor Conferences

20 أغسطس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

14 أغسطس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

30 يوليو 2024 15:01:00 بحسب Nasdaq GlobeNewswire